SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point after its recent earnings report, which, despite showing subscriber growth and exceeding revenue expectations, led to a notable sell-off. Community discussion is split between those viewing the price dip as an overreaction and a long-term buying opportunity, and those concerned about the cautious forward guidance, valuation, and the strategic implications of the potential Warner Bros. Discovery acquisition.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending after CEO Ryan Cohen and another board member significantly increased their stakes in the company through recent share purchases. This insider buying has ignited a strong bullish sentiment among investors, who are actively discussing the potential for a short squeeze and viewing the moves as a vote of confidence. The stock's resilience amidst broader market volatility further fuels community speculation about future catalysts.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending amidst discussions surrounding President Trump's escalating rhetoric on acquiring Greenland, which includes threats of tariffs against opposing nations. This has sparked concerns over US government finances and international relations, with some European entities reportedly divesting from US Treasuries. Community sentiment is deeply divided, with many anticipating further market volatility and a potential "Sell America" trend, while others view the current downturn as an overreaction and a "buy the dip" opportunity.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to recent positive Phase 1 clinical trial data for its eczema treatment, soquelitinib, which demonstrated strong efficacy and a favorable safety profile, initially fueling a significant surge in interest. This positive momentum is now tempered by a proposed $150 million public offering, sparking a community debate between those who see it as a strategic capital raise for a potentially breakthrough oral therapy and those concerned about dilution for an early-stage drug.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels is trending following its strategic acquisition of Australian Strategic Materials and a highly positive feasibility study for expanding rare earth processing capabilities. The community is actively discussing the company's pivotal role in bolstering the U.S. domestic supply chain for critical minerals, driven by surging demand for nuclear energy and materials vital for AI and defense technologies.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid heightened geopolitical tensions sparked by President Trump's aggressive rhetoric regarding Greenland and threats of new tariffs on European allies. This has fueled market volatility, with the community debating whether the current pullback is an overreaction or signals broader concerns, as attention also turns to upcoming BigTech earnings.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as reports indicate the U.S. government is establishing a new digital asset reserve to hold seized Bitcoin, shifting from prior selling policies and removing market pressure. This comes amidst heightened market volatility, which many in the community attribute to political rhetoric and broader macroeconomic concerns. Investor sentiment remains sharply divided, with intense debate around Bitcoin's role as a digital safe haven compared to traditional assets like gold and silver, while closely watching key technical support levels.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending on reports of a potential acquisition or significant stake by Zydus Lifesciences, reportedly backed by a fundraise. This M&A speculation, combined with recent robust revenue guidance for IBSRELA and a key patent extension for both products until 2041, has sparked community excitement about a potential bidding war. Investors are closely monitoring for confirmation, anticipating these developments to dramatically re-rate the stock and solidify its long-term market position.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as the broader software sector faces a significant sell-off, fueled by investor anxiety over AI's perceived impact on traditional SaaS models. Despite this, community sentiment is largely bullish, arguing AI strengthens CRM by enhancing workflows and data value, leading many to view the stock as "insanely oversold" and ripe for a rebound. Investors are actively discussing the long-term opportunity as Salesforce integrates AI into its core offerings.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is actively trending after independent lab tests confirmed its AI-1 smartphone battery achieves 935 Wh/L, outperforming competitors by 12%, alongside initial CES 2026 partnerships for smart eyewear. While bullish investors see this as crucial validation and a step towards commercialization, others remain skeptical, citing past delays with major smartphone OEMs and recent executive departures. The community is sharply divided on whether these recent developments signal a breakthrough or continued unfulfilled promises in the competitive battery market.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Increase in Short Interest

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest...

3 Undervalued Medical Instrument Stocks Poised to Grow in 2026

FMS, IART and STE trade below historical valuations. Easing cost pressure and improved execution set the stage for potential upside in 2026 for these companies.

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

FMS' acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Reaches New 12-Month Low - Here's Why

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sets New 12-Month Low - Time to Sell...

Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs

NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.

FMS or MASI: Which Is the Better Value Stock Right Now?

FMS vs. MASI: Which Stock Is the Better Value Option?

Do Options Traders Know Something About FMS Stock We Don't?

Investors need to pay close attention to Fresenius Medical Care stock based on the movements in the options market lately. 

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Fresenius Medical Care (ETR:FME) Stock Crosses Below 200-Day Moving Average - Should You Sell?

Fresenius Medical Care (ETR:FME) Shares Cross Below 200-Day Moving Average - Time to Sell...

Fresenius Medical Care (ETR:FME) Shares Cross Below 200 Day Moving Average - Time to Sell?

Fresenius Medical Care (ETR:FME) Share Price Crosses Below 200-Day Moving Average - What's Next...

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$21.11
Prev Close	$21.95
Open	$21.14
Dividend Yield	2.52%
50-Day Moving Average	$23.44
Beta	0.49
Avg. Volume	443,858.41
PE Ratio	15.93

52-Week High	$30.46
52-Week Low	$21.02
Market Capitalization	$12.72B
EPS (Annual)	$0.9915
Price to Book	0.84
Revenue Per Employee	$183,744.42
Enterprise Value/EBITDA	N/A

FMS
Fresenius Medical Care AG & Co. KGAA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FMS News

FMSFresenius Medical Care AG & Co. KGAA